NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CFO Jay Matushak sold 4,448 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $6.74, for a total value of $29,979.52. Following the completion of the sale, the chief financial officer now directly owns 41,592 shares of the company’s stock, valued at approximately $280,330.08. This represents a 9.66 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Jay Matushak also recently made the following trade(s):
- On Tuesday, March 11th, Jay Matushak sold 814 shares of NeueHealth stock. The stock was sold at an average price of $6.85, for a total value of $5,575.90.
- On Friday, March 7th, Jay Matushak sold 1,860 shares of NeueHealth stock. The stock was sold at an average price of $7.19, for a total transaction of $13,373.40.
- On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total transaction of $36,430.10.
NeueHealth Stock Performance
Shares of NeueHealth stock traded down $0.38 during trading hours on Monday, hitting $4.71. The company’s stock had a trading volume of 81,052 shares, compared to its average volume of 18,693. The stock has a market cap of $38.98 million, a price-to-earnings ratio of -0.09 and a beta of 0.56. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $7.66. The firm has a fifty day moving average of $7.21 and a 200-day moving average of $6.01.
Institutional Trading of NeueHealth
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada reduced their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.
View Our Latest Report on NeueHealth
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Read More
- Five stocks we like better than NeueHealth
- What Do S&P 500 Stocks Tell Investors About the Market?
- Can TikTok Stock Picks Really Make You Rich?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- The “Quality” Rotation: Back to Basics Investing
- Why Invest in High-Yield Dividend Stocks?
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.